138 related articles for article (PubMed ID: 25338958)
1. Inhibition of SATB1 expression in regulatory T cells contributes to hepatitis B virus-related chronic liver inflammation.
Li XF; Tian L; Wang YY; Kong HS; Dong YJ; Zhu QY; Ni Q; Chen Y
Mol Med Rep; 2015 Jan; 11(1):231-6. PubMed ID: 25338958
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of SATB1 Gene Inhibits the Immunosuppressive Function of Regulatory T Cells in Chronic Hepatitis B.
Wang Y; Li X; Kong H; Zhu Q; Dong Y; Liu X; Chen Y
Ann Clin Lab Sci; 2017 Aug; 47(4):403-408. PubMed ID: 28801365
[TBL] [Abstract][Full Text] [Related]
3. Telbivudine decreases proportion of peripheral blood CD4+CD25+CD127low T cells in parallel with inhibiting hepatitis B virus DNA.
Yan Z; Zhou J; Zhang M; Fu X; Wu Y; Wang Y
Mol Med Rep; 2014 May; 9(5):2024-30. PubMed ID: 24626572
[TBL] [Abstract][Full Text] [Related]
4. IL-35 expression in peripheral blood CD4(+) T cells from chronic hepatitis B virus-infected patients directly correlates with virus load.
Zhou Y; Zhang H; Li Y
Cytokine; 2015 May; 73(1):169-75. PubMed ID: 25752977
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
Shao X; Ma J; Jia S; Yang L; Wang W; Jin Z
Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338
[TBL] [Abstract][Full Text] [Related]
6. Enhanced functions of peripheral γδ T cells in chronic hepatitis B infection during interferon α treatment in vivo and in vitro.
Chen M; Hu P; Ling N; Peng H; Lei Y; Hu H; Zhang D; Ren H
PLoS One; 2015; 10(3):e0120086. PubMed ID: 25774808
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-35 modulates the balance between viral specific CD4
Yang L; Jia S; Shao X; Liu S; Zhang Q; Song J; Wang W; Jin Z
Virol J; 2019 Apr; 16(1):48. PubMed ID: 30992023
[TBL] [Abstract][Full Text] [Related]
8. Relations of regulatory T cells with hepatitis markers in chronic hepatitis B virus infection.
El-Badawy O; Sayed D; Badary MS; Abd-Alrahman ME; El-Feky MA; Thabit AG
Hum Immunol; 2012 Apr; 73(4):335-41. PubMed ID: 22342871
[TBL] [Abstract][Full Text] [Related]
9. [Alterations of IFN-γ and IL-4 of peripheral blood T cells in patients with chronic HBV infection].
Li M; Sun X; Zhou Z; Zhang X; Jin S; Gao Y; Gao Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):240-4. PubMed ID: 26927386
[TBL] [Abstract][Full Text] [Related]
10. mRNA expression of glucocorticoid receptor and serological and virological markers of chronic hepatitis B.
Mei B; Chen Y; Liu W; Li L; Wang C
Mol Med Rep; 2015 Mar; 11(3):2215-20. PubMed ID: 25394950
[TBL] [Abstract][Full Text] [Related]
11. Circulating CD4+CD25high regulatory T cells and expression of PD-1 and BTLA on CD4+ T cells in patients with chronic hepatitis B virus infection.
Nan XP; Zhang Y; Yu HT; Li Y; Sun RL; Wang JP; Bai XF
Viral Immunol; 2010 Feb; 23(1):63-70. PubMed ID: 20121403
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T-cell responses in chronic hepatitis B patients treated with nucleos(t)ide analogs compared with healthy subjects and untreated infected individuals.
Chen LY; Zhu LY; Yang BS; Bi MR; Yan BZ; Wang W; Ma YJ
Hepatogastroenterology; 2012; 59(120):2582-6. PubMed ID: 22626879
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression and dysfunction of TLR2 and its soluble form in chronic HBV infection and its regulation by antiviral therapy.
Huang Z; Ge J; Pang J; Liu H; Chen J; Liao B; Huang X; Zuo D; Sun J; Lu M; Zhang X; Hou J
Antiviral Res; 2015 Jun; 118():10-9. PubMed ID: 25771704
[TBL] [Abstract][Full Text] [Related]
14. Enhanced levels of interleukin-8 are associated with hepatitis B virus infection and resistance to interferon-alpha therapy.
Yang K; Guan SH; Zhang H; Pan Y; Wu YY; Wang AH; Sun BB
Int J Mol Sci; 2014 Nov; 15(11):21286-98. PubMed ID: 25407531
[TBL] [Abstract][Full Text] [Related]
15. Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy.
Tseng TC; Yu ML; Liu CJ; Lin CL; Huang YW; Hsu CS; Liu CH; Kuo SF; Pan CJ; Yang SS; Su CW; Chen PJ; Chen DS; Kao JH
Antivir Ther; 2011; 16(5):629-37. PubMed ID: 21817184
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
[TBL] [Abstract][Full Text] [Related]
17. [Clinical efficacy of various antiviral-based strategies to treat chronic hepatitis patients with positivity for hepatitis B e antigen and rtN236T mutation].
Yue W; Yuan H; Mao XR; Deng YD; Chen L
Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):184-8. PubMed ID: 23967738
[TBL] [Abstract][Full Text] [Related]
18. Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype.
Sonneveld MJ; Rijckborst V; Cakaloglu Y; Simon K; Heathcote EJ; Tabak F; Mach T; Boucher CA; Hansen BE; Zeuzem S; Janssen HL
Antivir Ther; 2012; 17(1):9-17. PubMed ID: 22267464
[TBL] [Abstract][Full Text] [Related]
19. Baseline hepatitis B surface antigen (HBsAg) as predictor of sustained HBsAg loss in chronic hepatitis B patients treated with pegylated interferon-α2a and adefovir.
Takkenberg RB; Jansen L; de Niet A; Zaaijer HL; Weegink CJ; Terpstra V; Dijkgraaf MG; Molenkamp R; Jansen PL; Koot M; Rijckborst V; Janssen HL; Beld MG; Reesink HW
Antivir Ther; 2013; 18(7):895-904. PubMed ID: 23639931
[TBL] [Abstract][Full Text] [Related]
20. Pegylated Interferon-ɑ (IFN-ɑ) Enhances the Inhibitory Effect of Natural Killer Cells on Regulatory T Cells via IFN-γ in Chronic Hepatitis B.
Yuan W; Huang D; Wu D; Chen Y; Ma K; Han M; Luo X; Yan W; Ning Q
J Infect Dis; 2021 Dec; 224(11):1878-1889. PubMed ID: 33870432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
